e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom
Kozo Morimoto, Akio Aono, Yoshiro Murase, Tsuyoshi Sekizuka, Atsuyuki Kurashima, Akiko Takaki, Yuka Sasaki, Yuriko Igarashi, Kinuyo Chikamatsu, Hajime Goto, Hiroyuki Yamada, Makoto Kuroda, Satoshi Mitarai
Source:
ERJ Open Res, 4 (3) 00150-2017; 10.1183/23120541.00150-2017
Journal Issue:
July
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kozo Morimoto, Akio Aono, Yoshiro Murase, Tsuyoshi Sekizuka, Atsuyuki Kurashima, Akiko Takaki, Yuka Sasaki, Yuriko Igarashi, Kinuyo Chikamatsu, Hajime Goto, Hiroyuki Yamada, Makoto Kuroda, Satoshi Mitarai. Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom. ERJ Open Res, 4 (3) 00150-2017; 10.1183/23120541.00150-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Nontuberculous mycobacterial lung disease caused by
Mycobacterium parascrofulaceum
in an immunocompetent patient
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006
Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018
Management of nontuberculous mycobacterial infections
Source: International Congress 2015 – ME9 Management of non-tuberculous mycobacterial (NTM) infections
Year: 2015
The management of non-tuberculous mycobacteria
Source: International Congress 2016 – New therapies for chronic respiratory infections
Year: 2016
A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010
Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Pulmonary mycobacterium xenopi infection in Japan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Simultaneous infection with nontuberculous and tuberculous mycobacteria
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Clinical importance of pulmonary nontuberculous mycobacteria isolated among HIV-positive individuals in Ghana
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Pulmonary disease caused by non-tuberculous mycobacteria. Descriptive study and comparison with mycobacterium tuberculosis
Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Year: 2011
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
Source: Eur Respir Rev 2009; 18: 299-301
Year: 2009
Screening non-tuberculous mycobacteria in patients with bronchiectasis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Burden of non-tuberculous mycobacterial pulmonary disease in Germany
Source: Eur Respir J , 49 (4) 1602109; DOI: 10.1183/13993003.02109-2016
Year: 2017
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
Source: Eur Respir J 2004; 23: 741-746
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept